Cargando…
Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patients
Clinical, epidemiological and experimental data identified the insulin-like growth factor-1 receptor (IGF1R) as a candidate therapeutic target in oncology. While this paradigm is based on well-established biological facts, including the potent anti-apoptotic and cell survival capabilities of the rec...
Autores principales: | Sinai-Livne, Tali, Pasmanik-Chor, Metsada, Cohen, Zoya, Tsarfaty, Ilan, Werner, Haim, Berger, Raanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197451/ https://www.ncbi.nlm.nih.gov/pubmed/32391121 http://dx.doi.org/10.18632/oncotarget.27566 |
Ejemplares similares
-
Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns
por: Sarfstein, Rive, et al.
Publicado: (2020) -
Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action
por: Aizen, Daniel, et al.
Publicado: (2018) -
Identification of BRCA1 As a Potential Biomarker for Insulin-Like Growth Factor-1 Receptor Targeted Therapy in Breast Cancer
por: Cohen-Sinai, Tali, et al.
Publicado: (2017) -
Basic and clinical significance of IGF-I-induced signatures in cancer
por: Werner, Haim, et al.
Publicado: (2010) -
MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression
por: Yaron-Saminsky, Danielle, et al.
Publicado: (2021)